PT - JOURNAL ARTICLE AU - Gábor Bogye AU - Georg Alfthan AU - Tamás Machay AU - László Zubovics TI - Enteral yeast–selenium supplementation in preterm infants AID - 10.1136/fn.78.3.F225 DP - 1998 May 01 TA - Archives of Disease in Childhood - Fetal and Neonatal Edition PG - F225--F226 VI - 78 IP - 3 4099 - http://fn.bmj.com/content/78/3/F225.short 4100 - http://fn.bmj.com/content/78/3/F225.full SO - Arch Dis Child Fetal Neonatal Ed1998 May 01; 78 AB - AIM To study the bioavailability of selenium enriched yeast in preterm infants living in a low selenium area (Hungary). METHODS Thirty six preterm infants were randomly assigned to two groups at birth with respect to selenium supplementation. In the supplemented group (n=18) infants received 4.8 mg of selenium enriched yeast containing 5 μg selenium daily. RESULTS In the supplemented group the serum selenium concentration increased from 36.1(±12.8) μg/l to 43.5 (7.9) μg/l and in the non-supplemented group it decreased from 34.4 (20.4) μg/l to 26.1 (16.6) μg/l from birth in two weeks. No complications or side effects as a result of supplementation were observed. CONCLUSIONS Selenium enriched yeast is a safe and an effective form of short term enteral selenium supplementation for preterm infants.